Episodes 166-180 of 746
Evaluating Dato-DXd for EGFR-Mutated Advanced NSCLC: Data from a Pooled Analysis
On the Frontlines of Non-Small Cell Lung CancerEvaluating Dato-DXd for EGFR-Mutated Advanced NSCLC: Data from a Pooled Analysis
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Project Oncology®Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Project Oncology®TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Active Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
On the Frontlines of Prostate CancerActive Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
On the Frontlines of Prostate CancerPersonalizing Prostate Cancer Surveillance: Insights from Canary PASS
Evolving Strategies in Limited-Stage Small Cell Lung Cancer Management
Deep Breaths: Updates from CHESTEvolving Strategies in Limited-Stage Small Cell Lung Cancer Management
- advertisement
Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Project Oncology®Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Project Oncology®Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Poster Pearl: Axatilimab’s Impact on Fibrosis-Dominant Organs in cGVHD
Project Oncology®Poster Pearl: Axatilimab’s Impact on Fibrosis-Dominant Organs in cGVHD
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
On the Frontlines of Prostate CancerEvolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
ADT Monotherapy for mHSPC: How to Identify the Right Patients
On the Frontlines of Prostate CancerADT Monotherapy for mHSPC: How to Identify the Right Patients
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
On the Frontlines of Prostate CancerRedefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
- advertisement
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerAdvancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerOptimizing Quality of Life in HER2+ Metastatic Breast Cancer
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
